Prolonged dexmedetomidine infusions in critically ill infants and children

Pamela D Reiter1, Molli Pietras, Emily L Dobyns

  • 1Department of Pharmacy, Center for Pediatric Medicine, The Children's Hospital, 13123 East 16th Ave, Denver, USA. reiter.pam@tchden.org

Indian Pediatrics
|May 12, 2009
PubMed

Insights

Prolonged infusions of dexmedetomidine (DEX) in critically ill children reduced the need for other sedatives and analgesics. DEX was generally well tolerated, with a slight decrease in heart rate upon initiation.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Intensive Care Unit Management

Background:

  • Prolonged sedation and analgesia are common in critically ill pediatric patients.
  • Dexmedetomidine (DEX) is an alpha-2 adrenergic agonist used for sedation and analgesia.
  • Limited data exist on the long-term use of DEX in pediatric intensive care settings.

Purpose of the Study:

  • To evaluate the institutional experience with prolonged dexmedetomidine (DEX) infusions in critically ill infants and children.
  • To assess the efficacy and tolerability of DEX in this population.

Main Methods:

  • Retrospective chart review of pediatric patients (up to 18 years) receiving DEX infusions for over 24 hours.
  • Data collected included DEX dosing, rationale for use, sedation scores, vital signs, and conventional analgesic/sedative requirements.
  • Analysis focused on changes in sedation scores, heart rate, blood pressure, and concomitant medication use.

Main Results:

  • Twenty-nine patients received DEX for a median of 76 hours (range 32-378 hours).
  • Common reasons for DEX use included facilitating extubation and reducing opioid/benzodiazepine use.
  • Sedation scores remained stable, and conventional analgesic/sedative use decreased.
  • A transient, statistically significant reduction in heart rate was observed upon initiation, but blood pressure remained unchanged.

Conclusions:

  • Prolonged dexmedetomidine infusions are effective in reducing the need for other sedatives and analgesics in critically ill children.
  • DEX was generally well tolerated, with a manageable decrease in heart rate.
  • Further research may clarify the clinical significance of heart rate changes with prolonged DEX use.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...